JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...
Skywatchers on Thursday evening, Feb. 6, will notice an eye-catching pairing-off between two of the brightest objects in the ...
LLC ("Catalent") for the production of JOTROL ™ softgel capsules to support Jupiter’s upcoming Phase 2a clinical trial in Parkinson’s disease. Under the terms of the agreement, Catalent will ...
I pick out North America’s celestial highlights for the week ahead (which also applies to northern hemisphere mid-northern ...
February’s night sky gives us the bright trio of Mars, Jupiter and Venus, according to NASA skywatch experts. “Venus blazes ...
A Month of Bright Planets Venus blazes at its brightest for the year after sunset, then Mars and Jupiter to rule the night ...
Jupiter Neurosciences Inc., a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based platform, ...
Jupiter Neurosciences (JUNS) conducted a Phase I study demonstrating that JOTROL achieves over nine times higher bioavailability compared to resveratrol used in earlier clinical trials (e.g ...
Mars, Venus, Jupiter and Saturn should be visible to the naked eye, but with a telescope you can spot Neptune and Uranus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback